Online citations, reference lists, and bibliographies.
← Back to Search

Diffuse Malignant Pleural Mesothelioma: Part II. Symptom Management.

M. E. Cordes, C. Brueggen
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Patients with diffuse malignant pleural mesothelioma (DMPM) experience multiple symptoms from their disease and treatment, which can affect all aspects of their lives. Dyspnea, cough, pain, fatigue, depression, weight loss, anorexia, and cachexia are the most common symptoms. Early, ongoing assessment and management of these symptoms are imperative to maximize quality of life for patients with DMPM.
This paper references
10.1136/bmj.301.6752.575
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.
L. Fallowfield (1990)
10.1016/S1462-3889(98)81276-3
Multicentre randomized controlled trial of a nursing intervention for breathlessness in patients with lung cancer: Update of study progress
M. Bredin (1998)
10.1016/S1010-7940(96)01008-1
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
O. Soysal (1997)
Nutritional oncology: Planning a winning strategy [Live chat transcript
F. Ottery (2001)
10.1016/S1010-7940(01)00995-2
Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control.
A. Martin-Ucar (2001)
juvant psychological therapy with cancer : A prospective randomized trial
S. Greer (1992)
10.2307/3522025
Nutrition: the forgotten ingredient in cancer care.
G. Wilkes (2000)
10.1188/03.CJON.35-38
Use of the Pleurx Pleural Catheter for the management of malignant pleural effusions.
Sara Brubacher (2003)
10.1007/s005200050254
Assessment of dyspnea in advanced cancer patients
I. Mancini (1999)
Rethinking nutritional support of the cancer patient: the new field of nutritional oncology.
F. Ottery (1994)
10.1016/S0147-9563(97)90005-4
The effect of a pulmonary rehabilitation program on self-efficacy, perception of dyspnea, and physical endurance.
Y. Scherer (1997)
10.1093/AJCN/66.3.683
Nutrition support in clinical practice: review of published data and recommendations for future research directions.
S. Klein (1997)
10.1046/J.1365-2648.1994.20040622.X
The subjective and psychosocial nature of breathlessness.
N. West (1994)
Nutritional issues facing lung cancer individuals
G. Wilkes (2003)
10.1177/104990910001700512
Hydrocodone for cough in advanced cancer
J. Homsi (2000)
10.1300/J088v08n03_07
Interpleural Analgesia for Analgesia Due to Metastatic Lung Cancer
N. Irick (2000)
Psychiatric aspects of palliative care
W. Breitbart (1998)
10.3109/9781420077391-31
Malignant pleural mesothelioma.
Nadgouda Vg (2001)
10.1016/S0885-3924(01)00367-0
Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
N. Shimoyama (2002)
10.1001/JAMA.1997.03540470036018
End-of-life care.
D. Sulmasy (1997)
Supportive nutrition to prevent cachexia and improve quality of life.
Ottery Fd (1995)
10.1001/ARCHPSYC.1995.03950140007002
Depression in patients with cancer. Diagnosis, biology, and treatment.
J. S. McDaniel (1995)
10.1177/104990919901600113
Nebulized opioids to treat dyspnea
S. Chandler (1999)
10.1136/BMJ.318.7188.901
Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer.
M. Bredin (1999)
10.1378/CHEST.113.3.723
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.
J. Herndon (1998)
10.1089/109662101753381656
End of Life.
Bijay Sanjeev (2001)
10.1183/09031936.01.00225601
Management of malignant pleural effusions.
V. Antony (2001)
Measurement of fatigue in people with cancer.
H. Wu (2001)
10.1016/S0885-3924(96)00327-2
Dyspnea: pathophysiology and assessment.
C. Ripamonti (1997)
Nutrition handbook for nursing practice (3rd ed.)
S. G. Dudak (1997)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
Meges - trol acetate in cancer anorexia and weight loss
N. Tchekmedyian (1992)
10.1016/S0885-3924(01)00255-X
Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer.
E. Smith (2001)
10.1016/0885-3924(95)00056-5
Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer.
L. Degner (1995)
Fatigue in the cancer patient: a conceptual approach to a clinical problem.
J. Aistars (1987)
Malignant mesothelioma of the pleural space.
S. Grondin (1999)
The symptoms of advanced cancer.
S. Donnelly (1995)
Lung cancer: Symptom management and supportive care
R. Ingle (2001)
Management of malignant pleural effusions and ascites.
A. Covey (2005)
10.1378/CHEST.119.6.1641
Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.
G. Pien (2001)
10.1007/s005200100296
Respiratory problems in advanced cancer
C. Ripamonti (2002)
10.1097/01893697-200119020-00038
Cancer-related fatigue: guidelines for evaluation and management.
R. Portenoy (1999)
10.1016/S0140-6736(05)66809-2
Fatigue
Richard J. Barnett (2005)
10.1097/00002820-200004000-00002
Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms.
C. Tishelman (2000)
10.1002/JSO.1143
Survival after conservative (palliative) management of pleural malignant mesothelioma
N. Merritt (2001)
10.1148/RADIOLOGY.210.1.R99DC04277
Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.
E. Marom (1999)
10.1002/cncr.1984.53.s10.2243
Measurement of Depression in Patients With Cancer
J. Endicott (1984)
10.1097/00001622-200207000-00004
Dyspnea: the continuing challenge of palliative management
S. Legrand (2002)
10.1016/S0960-7404(98)00019-X
Malignant pleural mesothelioma: a problematic review.
T. L. Moskal (1998)
10.1007/s005200100252
Important drugs for cough in advanced cancer
J. Homsi (2001)
10.1002/(SICI)1097-0142(20000301)88:5<1175::AID-CNCR30>3.0.CO;2-N
Symptom and quality of life survey of medical oncology patients at a Veterans Affairs medical center
V. Chang (2000)
10.1016/S0749-2081(87)80014-1
Symptom distress--the concept: past and present.
V. Rhodes (1987)
10.1200/JCO.1993.11.1.152
Body-composition changes in patients who gain weight while receiving megestrol acetate.
C. Loprinzi (1993)
10.1097/00128594-200110000-00025
Use of small-bore vs. large-bore chest tubes for treatment of malignant pleural effusions.
U. Prakash (2001)
Exercise and the treatment of wasting: aging and human immunodeficiency virus infection.
W. Evans (1998)
10.1016/S0003-4975(99)01482-4
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
J. Putnam (2000)
10.1378/CHEST.120.1.19
Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.
W. Parulekar (2001)
10.1024/1012-5302.12.6.352
Perceptions of symptom distress in lung cancer patients: II. Behavioral assessment by primary family caregivers.
M. Lobchuk (1997)
Rethinking nutritional support of the cancer patient: the new field of nutritional oncology.
Ottery Fd (1994)
10.1007/s005200050255
Management of dyspnea in advanced cancer patients
C. Ripamonti (1999)
10.1016/S0885-3924(01)00391-8
Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea.
P. Coyne (2002)
Nutritional issues facing lung
G. Wilkes (2003)
Fatigue and the postsurgical patient
D. Rhoton (1982)
10.1016/S0885-3924(97)00022-5
Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers.
M. Lobchuk (1997)
trition support in clinical practice : Review of published data and recommendations for future research directions
S. Klein (1997)
The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer.
B. Piper (1998)
Cancer-related depression: Part II--Neurologic alterations and evolving approaches to psychopharmacology.
N. Lovejoy (2000)
10.1023/A:1024929829627
Measurement of Fatigue in Cancer Patients: Development and Validation of the Fatigue Symptom Inventory
D. Hann (2004)
10.1016/S0885-3924(02)00400-1
Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else?
K. Tanaka (2002)
Nutritional disturbances.
P. Senecal (1962)
10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
The rapid assessment of fatigue severity in cancer patients
T. Mendoza (1999)
10.1002/CNCR.2820690532
Megestrol acetate in cancer anorexia and weight loss
N. S. Tchekmedyian (1992)
10.5860/choice.33-1827
Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.
D. Washington (1994)
10.1007/978-3-642-16483-5_803
The cancer cachexia syndrome.
M. Puccio (1997)
Cancer-related depression: Part I--Neurologic alterations and cognitive-behavioral therapy.
N. Lovejoy (2000)
10.1177/0115426595010004129
The clinical assessment of adult patients with protein energy malnutrition.
G. L. Hill (1995)
10.1080/08039480310002147
Measurement of depression in patients with chronic obstructive pulmonary disease (COPD)
K. Stage (2003)
Management of malignant pleural effusion.
J. Taubert (2001)
10.1177/082585979701300308
Nebulized Opioids in the Treatment of Dyspnea
P. C. Quelch (1997)
10.1200/JCO.1999.17.10.3299
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
C. Loprinzi (1999)
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.
P. Meek (1999)
10.1016/S0140-6736(95)92013-7
Mesothelioma
H. Irvine (1995)
10.1007/978-3-642-82028-1_2
Management of cancer pain.
J. Bonica (1984)
10.1188/02.ONF.925-933
Dyspnea: recognizing and managing an invisible problem.
R. Wickham (2002)
Malignant mesothelioma of the pleura.
D. Reddy (1959)
10.1097/00006842-197707000-00007
Comparative Studies of Psychological Function in Patients with Advanced Cancer—I. Self‐Reported Depressive Symptoms
M. Plumb (1977)
10.1016/0885-3924(89)90057-2
Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer.
E. Bruera (1989)
10.7748/NS2002.02.16.24.33.C3160
Non-pharmacological treatment of breathlessness.
C. Cox (2002)
10.1016/S0885-3924(02)00394-9
Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer.
K. Tanaka (2002)
10.1016/S0140-6736(83)92652-1
NUTRITIONAL SUPPORT
V. Todorović (1983)
10.1097/00000446-200004000-00041
Nutrition: the forgotten ingredient in cancer care.
G. Wilkes (2000)
10.1136/bmj.304.6828.675
Adjuvant psychological therapy for patients with cancer: a prospective randomised trial.
S. Greer (1992)
10.1016/S0749-2081(05)80008-7
Fatigue and weakness in cancer patients: the symptoms experience.
L. Nail (1995)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1503/cmaj.050909
Dyspnea
P. Moorehead (2005)
tubes for treatment of malignant pleural effusions
J. Peto (1999)
10.1177/0148607192016003197
Jonathan E. Rhoads Lecture. Body composition research: implications for the practice of clinical nutrition.
G. Hill (1992)
Dyspnea: Recognizing and
R. Wickham (2002)
Supportive nutrition to prevent cachexia and improve quality of life.
F. Ottery (1995)
10.1016/S0885-3924(02)00376-7
Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer.
K. Tanaka (2002)
Malignant pleural mesothelioma.
N. Knudsen (1989)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar